Nonalcoholic fatty liver disease (NAFLD) clusters in families, but the only known common genetic variants influencing risk are near PNPLA3. We sought to identify additional genetic variants influencing NAFLD using genome-wide association (GWA) analysis of computed tomography (CT) measured hepatic steatosis, a non-invasive measure of NAFLD, in large population based samples. Using variance components methods, we show that CT hepatic steatosis is heritable (∼26%–27%) in family-based Amish, Family Heart, and Framingham Heart Studies (n = 880 to 3,070). By carrying out a fixed-effects meta-analysis of genome-wide association (GWA) results between CT hepatic steatosis and ∼2.4 million imputed or genotyped SNPs in 7,176 individuals from the Old Order Amish, Age, Gene/Environment Susceptibility-Reykjavik study (AGES), Family Heart, and Framingham Heart Studies, we identify variants associated at genome-wide significant levels (p<5×10−8) in or near PNPLA3, NCAN, and PPP1R3B. We genotype these and 42 other top CT hepatic steatosis-associated SNPs in 592 subjects with biopsy-proven NAFLD from the NASH Clinical Research Network (NASH CRN). In comparisons with 1,405 healthy controls from the Myocardial Genetics Consortium (MIGen), we observe significant associations with histologic NAFLD at variants in or near NCAN, GCKR, LYPLAL1, and PNPLA3, but not PPP1R3B. Variants at these five loci exhibit distinct patterns of association with serum lipids, as well as glycemic and anthropometric traits. We identify common genetic variants influencing CT–assessed steatosis and risk of NAFLD. Hepatic steatosis associated variants are not uniformly associated with NASH/fibrosis or result in abnormalities in serum lipids or glycemic and anthropometric traits, suggesting genetic heterogeneity in the pathways influencing these traits.
Vyšlo v časopise: Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits. PLoS Genet 7(3): e32767. doi:10.1371/journal.pgen.1001324 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001324
1. ClarkJM
2006 The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40 S5 10
2. KleinerDE
BruntEM
Van NattaM
BehlingC
ContosMJ
2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 1313 1321
3. HarrisonSA
Neuschwander-TetriBA
2004 Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8 861 879
4. FanJG
ZhuJ
LiXJ
ChenL
LuYS
2005 Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20 1825 1832
5. StrubenVM
HespenheideEE
CaldwellSH
2000 Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108 9 13
6. WillnerIR
WatersB
PatilSR
ReubenA
MorelliJ
2001 Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 2957 2961
7. SchwimmerJB
CeledonMA
LavineJE
SalemR
CampbellN
2009 Heritability of nonalcoholic fatty liver disease. Gastroenterology 136 1585 1592
8. RomeoS
KozlitinaJ
XingC
PertsemlidisA
CoxD
2008 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40 1461 1465
9. KotronenA
JohanssonLE
JohanssonLM
RoosC
WesterbackaJ
2009 A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52 1056 1060
10. IwasakiM
TakadaY
HayashiM
MinamiguchiS
HagaH
2004 Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78 1501 1505
11. SaadehS
YounossiZM
RemerEM
GramlichT
OngJP
2002 The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 745 750
12. LimanondP
RamanSS
LassmanC
SayreJ
GhobrialRM
2004 Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230 276 280
13. TeslovichTM
MusunuruK
SmithAV
EdmondsonAC
StylianouIM
2010 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466 707 713
14. SpeliotesEK
WillerCJ
BerndtSI
MondaKL
ThorleifssonG
2010 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42 937 948
15. VoightBF
ScottLJ
SteinthorsdottirV
MorrisAP
DinaC
2010 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42 579 589
16. DupuisJ
LangenbergC
ProkopenkoI
SaxenaR
SoranzoN
2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42 105 116
17. ZhongH
YangX
KaplanLM
MolonyC
SchadtEE
2010 Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 86 581 591
18. YuanX
WaterworthD
PerryJR
LimN
SongK
2008 Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 83 520 528
19. PetersenKF
DufourS
HaririA
Nelson-WilliamsC
FooJN
2010 Apoliporpotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362 1082 1089
20. PriceAL
ButlerJ
PattersonN
CapelliC
PascaliVL
2008 Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 4 e236 doi:10.1371/journal.pgen.0030236
21. SpeliotesEK
ButlerJL
PalmerCD
VoightBF
ConsortiumtG
2010 PNPLA3 variants specifically confer increased risk for histologic NAFLD but not metabolic disease. Hepatology 52 904 912
22. KathiresanS
PurcellS
ArdissinoD
2009 Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41 334 341
23. ValentiL
Al-SerriA
DalyAK
GalmozziE
RamettaR
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51 1209 1217
24. SpeliotesEK
MassaroJM
HoffmannU
RamachandranV
MeigsJB
2010 Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 51 1979 1987
25. SaxenaR
LyssenkoV
BurttNP
de BakkerPI
2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 1331 1336
26. WillerCJ
SannaS
JacksonAU
ScuteriA
BonnycastleLL
2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 161 169
27. KathiresanS
PelosoGM
DemissieS
2009 Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41 56 65
28. KathiresanS
MelanderO
GuiducciC
SurtiA
2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 189 197
29. LindgrenCM
HeidIM
RandallJC
LaminaC
2009 Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 5 e1000508 doi:10.1371/journal.pgen.1000508
30. BeerNL
TribbleND
McCullochLJ
JohnsonPR
2009 The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18 4081 4088
31. BurkeJE
DennisEA
2009 Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res 50 Suppl S237 242
32. BurkeJE
2009 Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 23 49 59
33. HeS
McPhaulC
LiJZ
GarutiR
KinchLN
2009 A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285 6706 6715
34. RauchU
FengK
ZhouXH
2001 Neurocan: a brain chondroitin sulfate proteoglycan. Cell Mol Life Sci 58 1842 1856
35. AgiusL
2008 Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 414 1 18
36. AulchenkoYS
RipkeS
IsaacsA
van DuijnCM
2007 GenABEL: an R library for genome-wide association analysis. Bioinformatics 23 1294 1296
37. RampersaudE
BielakLF
ParsaA
ShenH
PostW
2008 The association of coronary artery calcification and carotid artery intima-media thickness with distinct, traditional coronary artery disease risk factors in asymptomatic adults. Am J Epidemiol 168 1016 1023
38. SorkinJ
PollinTI
O'ConnellJR
MitchellBD
2005 Exploring the genetics of longevity in the Old Order Amish. Mech Ageing Dev 126 347 350
39. HigginsM
ProvinceM
HeissG
EckfeldtJ
EllisonRC
1996 NHLBI Family Heart Study: objectives and design. Am J Epidemiol 143 1219 1228
40. CarrJJ
NelsonJC
WongND
McNitt-GrayM
AradY
2005 Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 35 43
41. DawberT
1980 The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, MA Harvard University Press
42. KannelWB
FeinleibM
McNamaraPM
GarrisonRJ
CastelliWP
1979 An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110 281 290
43. SplanskyGL
CoreyD
YangQ
AtwoodLD
CupplesLA
2007 The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165 1328 1335
44. SpeliotesEK
FosterMC
SahaniDV
2008 Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23 894 899
45. ChenMH
LarsonMG
HsuYH
GuoCY
2010 A three-stage approach for genome-wide association studies with family data for quantitative traits. BMC Genet 11 40
46. PriceAL
PattersonNJ
PlengeRM
WeinblattME
ShadickNA
2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909
47. AlmasyL
BlangeroJ
1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62 1198 1211
48. ThorleifssonG
WaltersGB
GudbjartssonDF
SulemP
2009 Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41 18 24
49. ChalasaniNP
SanyalAJ
KowdleyKV
RobuckPR
HoofnagleJ
2009 Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials 30 88 96
50. PurcellS
NealeB
Todd-BrownK
ThomasL
FerreiraMA
2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
